AbbVie (ABBV) FY2024 results: revenue $56.3 billion, up 3.7% on the year
AbbVie Inc. (ABBV) reported revenue of $56.3 billion for fiscal 2024, the year ended 31 December 2024, up 3.7% on the year before. Net income was $4.3 billion, down 12.0%, and diluted earnings per share $2.39. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2025.
Revenue
$56.3 billion
+3.7% on the year
FY2017FY2024
Operating margin
16.2%
23.5% a year earlier
FY2017FY2024
Net income
$4.3 billion
-12.0% on the year
FY2017FY2024
Diluted EPS
$2.39
-12.1% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
18,806
22,839
24,943
-17.7%
Capital expenditure
974
777
695
+25.4%
Free cash flow
17,832
22,062
24,248
-19.2%
Free cash flow margin
31.7%
40.6%
41.8%
Cash from investing
-20,820
-2,009
-623
Cash from financing
-5,211
-17,222
-24,803
Depreciation and amortisation
8,386
8,698
8,467
-3.6%
Share-based compensation
911
747
671
+22.0%
Buybacks
1,708
1,972
1,487
-13.4%
Dividends paid
11,025
10,539
10,043
+4.6%
Dividend per share
$6.29
$5.99
$5.71
+5.0%
Diluted shares, weighted
1,773m
1,773m
1,778m
0.0%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
3,325
10,360
17,254
-67.9%
Non-controlling interest
39.0
37.0
33.0
+5.4%
Short-term borrowings
0.0
0.0
1.0
Debt
66,841
59,245
63,128
+12.8%
Operating lease liabilities
697
735
754
-5.2%
Finance lease liabilities
23.0
27.0
17.0
-14.8%
Other liabilities
64,236
64,307
57,618
-0.1%
Total liabilities and equity
135,161
134,711
138,805
+0.3%
Fixed assets
5,134
4,989
4,935
+2.9%
Goodwill
34,956
32,293
32,156
+8.2%
Intangible assets
60,068
55,610
67,439
+8.0%
Investments
310
306
269
+1.3%
Cash and equivalents
5,524
12,814
9,201
-56.9%
Receivables
10,919
11,155
11,254
-2.1%
Inventory
4,181
4,099
3,579
+2.0%
Other assets
14,069
13,445
9,972
+4.6%
Total assets
135,161
134,711
138,805
+0.3%
10-K for the year ended 31 December 2024, filed 14 February 2025: the filing.